Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Grant or award Director acquired 14,624 shares (grant or award)
  2. 4 Open-market buy Director bought 910,000 shares at $5.45 ($4,959,318)
  3. 4 Open-market buy Director bought 150,000 shares at $5.35 ($801,900)
  4. 4 Open-market buy SVP, Chief Medical Officer bought 3,000 shares at $5.59 ($16,755)
  5. 4 Open-market buy President and CEO bought 10,000 shares at $5.34 ($53,370)
  6. 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 7,170 shares at $6.00 ($43,020)
  7. 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 7,170 shares at $5.50 ($39,435)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale SVP, Chief Medical Officer sold 2,555 shares at $4.70 ($12,006)
  15. 4 Open-market sale Sr. VP, Drug Development sold 6,844 shares at $4.70 ($32,187)
  16. 4 Open-market sale VP, Fin. and Admin., CFO sold 4,397 shares at $4.70 ($20,662)
  17. 5 Insider Annual Insider Trading Report
  18. 4 Open-market buy Director bought 1,136,363 shares at $4.40 ($4,999,997)
  19. 4 Open-market buy Director bought 11,059 shares at $3.95 ($43,727)
  20. 4 Open-market buy Director bought 8,844 shares at $3.96 ($35,024)

Page 21 of 29 · 564 filings